Evaluation Friday, August 23, 2024

Friday, August 23, 2024

Question Title

* 1. Chronic Refractory Osteomyelitis
Instructor: J. Benjamin Jackson, III, MD

	Strongly Disagree	Disagree	Agree	Strongly Agree	N/A
Objective: HBO's role discussed, weight of clinical and laboratory evidence presented and an optimal role for introduction of HBO therapy identified.	Objective: HBO's role discussed, weight of clinical and laboratory evidence presented and an optimal role for introduction of HBO therapy identified. Strongly Disagree	Objective: HBO's role discussed, weight of clinical and laboratory evidence presented and an optimal role for introduction of HBO therapy identified. Disagree	Objective: HBO's role discussed, weight of clinical and laboratory evidence presented and an optimal role for introduction of HBO therapy identified. Agree	Objective: HBO's role discussed, weight of clinical and laboratory evidence presented and an optimal role for introduction of HBO therapy identified. Strongly Agree	Objective: HBO's role discussed, weight of clinical and laboratory evidence presented and an optimal role for introduction of HBO therapy identified. N/A
Objective: Definition of what constitutes osteomyelitis, chronic osteomyelitis, and chronic refractory osteomyelitis are defined.	Objective: Definition of what constitutes osteomyelitis, chronic osteomyelitis, and chronic refractory osteomyelitis are defined. Strongly Disagree	Objective: Definition of what constitutes osteomyelitis, chronic osteomyelitis, and chronic refractory osteomyelitis are defined. Disagree	Objective: Definition of what constitutes osteomyelitis, chronic osteomyelitis, and chronic refractory osteomyelitis are defined. Agree	Objective: Definition of what constitutes osteomyelitis, chronic osteomyelitis, and chronic refractory osteomyelitis are defined. Strongly Agree	Objective: Definition of what constitutes osteomyelitis, chronic osteomyelitis, and chronic refractory osteomyelitis are defined. N/A
Objective: Understand standard management procedures are discussed and incidence of non response summarized.	Objective: Understand standard management procedures are discussed and incidence of non response summarized. Strongly Disagree	Objective: Understand standard management procedures are discussed and incidence of non response summarized. Disagree	Objective: Understand standard management procedures are discussed and incidence of non response summarized. Agree	Objective: Understand standard management procedures are discussed and incidence of non response summarized. Strongly Agree	Objective: Understand standard management procedures are discussed and incidence of non response summarized. N/A

Other comment (Optional):

Question Title

* 2. Sudden Sensorineural Hearing Loss
Instructor: Dick Clarke, CHT

	Strongly Disagree	Disagree	Agree	Strongly Agree	N/A
Objective: Identify known and postulated sudden hearing loss etiologies.	Objective: Identify known and postulated sudden hearing loss etiologies. Strongly Disagree	Objective: Identify known and postulated sudden hearing loss etiologies. Disagree	Objective: Identify known and postulated sudden hearing loss etiologies. Agree	Objective: Identify known and postulated sudden hearing loss etiologies. Strongly Agree	Objective: Identify known and postulated sudden hearing loss etiologies. N/A
Objective: Describe evidence of cochlear blood flow and oxygen pressure declines as a basis for oxygen supplementation.	Objective: Describe evidence of cochlear blood flow and oxygen pressure declines as a basis for oxygen supplementation. Strongly Disagree	Objective: Describe evidence of cochlear blood flow and oxygen pressure declines as a basis for oxygen supplementation. Disagree	Objective: Describe evidence of cochlear blood flow and oxygen pressure declines as a basis for oxygen supplementation. Agree	Objective: Describe evidence of cochlear blood flow and oxygen pressure declines as a basis for oxygen supplementation. Strongly Agree	Objective: Describe evidence of cochlear blood flow and oxygen pressure declines as a basis for oxygen supplementation. N/A
Objective: Summarize laboratory and clinical reports of hyperbaric oxygen’s use.	Objective: Summarize laboratory and clinical reports of hyperbaric oxygen’s use. Strongly Disagree	Objective: Summarize laboratory and clinical reports of hyperbaric oxygen’s use. Disagree	Objective: Summarize laboratory and clinical reports of hyperbaric oxygen’s use. Agree	Objective: Summarize laboratory and clinical reports of hyperbaric oxygen’s use. Strongly Agree	Objective: Summarize laboratory and clinical reports of hyperbaric oxygen’s use. N/A
Objective: Provide a clinical management algorithm.	Objective: Provide a clinical management algorithm. Strongly Disagree	Objective: Provide a clinical management algorithm. Disagree	Objective: Provide a clinical management algorithm. Agree	Objective: Provide a clinical management algorithm. Strongly Agree	Objective: Provide a clinical management algorithm. N/A

Other comment (Optional):

Question Title

* 3. Resources for Continuing Education
Instructor: Dick Clarke, CHT

	Strongly Disagree	Disagree	Agree	Strongly Agree	N/A
Objective: Participants will become familiar with industry organizations, continuing education sources, literature sources, and professional development.	Objective: Participants will become familiar with industry organizations, continuing education sources, literature sources, and professional development. Strongly Disagree	Objective: Participants will become familiar with industry organizations, continuing education sources, literature sources, and professional development. Disagree	Objective: Participants will become familiar with industry organizations, continuing education sources, literature sources, and professional development. Agree	Objective: Participants will become familiar with industry organizations, continuing education sources, literature sources, and professional development. Strongly Agree	Objective: Participants will become familiar with industry organizations, continuing education sources, literature sources, and professional development. N/A

Other comment (Optional):

Question Title

* 4. Completion of this question denotes the same as if my electronic signature were affixed to this document. I attest to the completion of this educational activity.

Name

Company

Email Address